haylaavo

SHASUNPHAR

SHASUNPHAR · NSE · inactive
428.55
+21.95 (+5.40%)
as of 17 Nov 2015 close
Open
410.60
High
433.00
Low
408.00
Prev close
406.60
52w high
433.00
17 Nov 2015
52w low
209.40
17 Nov 2014
VWAP
424.17
Delivery %
41.6%
of volume
Volume 5.07 L · turnover ₹21.51 Cr · NSE bhavcopy (official close) · history since 28 Jan 2011
Series
EQ
F&O
No
Status
Inactive since 18 Nov 2015

Formerly SHASUNCHEM (until 28 Jan 2011). Earlier name: Shasun Chemicals and Drugs Limited (until 28 Jan 2011).

Source: NSE equity master · as of 17 Nov 2015

Daily · NSE EOD
Exchange announcements
Source: NSE corporate filings · latest Today 20:24 IST
  • 18 Oct 2007 15:15
    Exchange query

    Shasun Chemicals And Drugs Ltd. has informed the Exchange that "This is with reference to the article in the Economic Times dated October 18, 2007, stating Reliance, Mylan & Ranbaxy eye Shasun's API biz'. We would like to bring to notice that Shasun is not looking to sell off any part of its business. The news items are based on mere rumours and are hence speculative in nature".

  • 22 Feb 2007 11:10
    Exchange query

    Shasun Chemicals And Drugs Ltd. has informed the Exchange that "This in is respect to the media article : 'Ranbaxy says no plans to issue US shares' that appeared in The Economic Times of Tuesday, 20th February 2007. Shasun Chemicals and Drugs has been erroneously cited as being in the race to buy Ranbaxy's unit in Ireland. The Company would like to clarify that the news item is speculative and we deny any such development at the moment. We re-iterate that as part of the Listing Agreement, any corporate development would be first intimated to the stock exchanges."

  • 04 Jan 2006 24:00
    Exchange query

    Clarification of News : The media had reports that Shasun Chemicals and Drugs Limited may acquire a plant in Europe in contract manufacturing space. The Exchange, in order to verify the accuracy or otherwise of the information reported in the media and to inform the market place so that the interest of the investors is safeguarded, had written to the officials of the company. Shasun Chemicals and Drugs Ltd. has vide its letter inter-alia stated, "We would like to clarify that as part of our inorganic growth strategy, we are in talks with various companies at different occasions. These are prel

Coming next in news
Arrives in Phase 3. Nothing here is estimated or filled in — we only show data we have.
  • Results & board-meeting calendar
  • Dividend, split, AGM calendar
  • Headlines with source and timestamp
  • Two-line factual filing summaries